Keywords: exonhit, mitsubishi, pharma, safe-hit, deal, french, firm

ExonHit and Mitsubishi Pharma in Safe-Hit deal

Article | 20 September 2004

French firm ExonHit Therapeutics, which focuses on alternative RNAsplicing, says it has signed a Safe-Hit toxicity profiling services agreement with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Mitsubishi Pharma

Go to company listing